Washington, United States — US experts met Thursday to assess whether to grant emergency approval for Pfizer-BioNTech’s COVID-19 vaccine and allow America to become the next country to move ahead with mass immunization.
The independent committee of experts convened by the Food and Drug Administration (FDA) will hold a non-binding vote at the end of the day, and the US regulator will determine after that whether to issue an emergency use authorization (EUA).
The arguments in favor seem to be overwhelming — it has already been greenlit by Britain and Canada — and the full results of a huge clinical trial of the vaccine were published Thursday in the New England Journal of Medicin…
Keep on reading: US considers Pfizer COVID-19 vaccine approval